Finepoint Capital LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Finepoint Capital LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$9,876
-99.9%
1,545,589
-2.6%
3.19%
-36.1%
Q3 2022$15,194,000
+43.3%
1,586,043
+65.2%
5.00%
+36.3%
Q2 2022$10,601,000960,2003.66%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders